Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alpha Cognition Inc. - Common Stock (NQ:ACOG)

8.630 -0.320 (-3.58%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	202,116
Open	8.950
Bid (Size)	9.570 (600)
Ask (Size)	9.800 (100)
Prev. Close	8.950
Today's Range	8.490 - 9.160
52wk Range	4.500 - 10.00
Shares Outstanding	146,925,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alpha Cognition Q2 Earnings Call Highlights ↗

Today 18:04 EDT

Alpha Cognition (NASDAQ:ACOG) reported second-quarter 2026 net product revenue of approximately $6 million from its Alzheimer’s treatment ZUNVEYL, up about 71% sequentially from $3.5 million in the...

Via MarketBeat

Alpha Cognition Q2 2026 Earnings Call Transcript ↗

Today 17:20 EDT

Alpha Cognition (NASDAQ:ACOG) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by...

Via Benzinga

Performance

YTD	+32.8%	+32.8%
1 Month	+7.2%	+7.2%
3 Month	+51.9%	+51.9%
6 Month	+62.8%	+62.8%
1 Year	-13.6%	-13.6%

More News

Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update

Today 16:05 EDT

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update

August 03, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (NASDAQ:ACOG) Q1 Revenue Meets Estimates as Commercial Momentum Builds ↗

May 14, 2026

Via Chartmill

Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q4 Revenue Miss Amid Strong Alzheimer's Drug Launch ↗

March 26, 2026

Via Chartmill

Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease

July 29, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit

July 10, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

June 23, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease

June 16, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease

June 09, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Q1 Earnings Call Highlights ↗

May 14, 2026

Via MarketBeat

Alpha Cognition (ACOG) Q1 2026 Earnings Transcript ↗

May 14, 2026

Via The Motley Fool

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

May 14, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

April 28, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences

April 27, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

April 20, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 15, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury

April 01, 2026

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425

April 01, 2026

Via Newsfile

Alpha Cognition (ACOG) Q4 2025 Earnings Transcript ↗

April 01, 2026

Via The Motley Fool

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

March 26, 2026

From Alpha Cognition Inc.

Via Business Wire

Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗

March 15, 2026

Via The Motley Fool

Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗

March 15, 2026

Via The Motley Fool

Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

March 13, 2026

From Alpha Cognition Inc.

Via Business Wire

Frequently Asked Questions

Is Alpha Cognition Inc. - Common Stock publicly traded?

Yes, Alpha Cognition Inc. - Common Stock is publicly traded.

What exchange does Alpha Cognition Inc. - Common Stock trade on?

Alpha Cognition Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Alpha Cognition Inc. - Common Stock?

The ticker symbol for Alpha Cognition Inc. - Common Stock is ACOG on the Nasdaq Stock Market

What is the current price of Alpha Cognition Inc. - Common Stock?

The current price of Alpha Cognition Inc. - Common Stock is 8.630

When was Alpha Cognition Inc. - Common Stock last traded?

The last trade of Alpha Cognition Inc. - Common Stock was at 08/13/26 04:00 PM ET

What is the market capitalization of Alpha Cognition Inc. - Common Stock?

The market capitalization of Alpha Cognition Inc. - Common Stock is 1.27B

How many shares of Alpha Cognition Inc. - Common Stock are outstanding?

Alpha Cognition Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.